Trials / Recruiting
RecruitingNCT05015660
Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing
LEFT Bundle Pacing vs Standard Right Ventricular Pacing for Heart Failure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,300 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
High burden right ventricular (RV) pacing has been shown to increase cardiovascular mortality, incidence of heart failure (HF), worsen left ventricular (LV) function and accelerate the development of atrial fibrillation (AF). High percentage ventricular pacing and wider paced QRS in the setting of normal baseline LV ejection fractions have consistently been shown to be independent risk factors for pacing-induced cardiomyopathy. Left bundle branch pacing (LBBP) has emerged as a potential alternative pacing mechanism that may avoid LV dyssynchrony and pacing-induced LV dysfunction by mimicking native electrical conduction.
Detailed description
We hypothesize that in patients with high degree AV block with anticipated ventricular pacing \>90%, and an EF \>35% patients undergoing LBBP will demonstrate a significantly lower number of the primary composite endpoint of cardiovascular death, heart failure events, and change in LVESVi as compared to standard RV pacing. Echos will be performed at baseline, 12, 24, and 36 months. NTproBNPs are performed at baseline and follow-up. There will be a core echo lab, and blinded adjudication of ECGs and events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Left bundle branch pacing lead | Implantation of a left bundle branch pacing lead via sheath, to perform selective or non-selective pacing |
| DEVICE | Right ventricular active fixation lead | Active fixation lead (standard) |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2026-12-01
- Completion
- 2030-01-01
- First posted
- 2021-08-20
- Last updated
- 2026-03-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05015660. Inclusion in this directory is not an endorsement.